Clinical Value of Inflammatory Indexes in Predicting Post-Transplantation Prognosis in Hepatocellular Carcinoma: A Retrospective Cohort Study
Open Access
- 1 July 2026
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-20
Abstract
Liver transplantation is key for HCC treatment. Inflammatory indexes offer non-invasive, accessible prognostic insights for hepatocellular carcinoma patients.Keywords
This publication has 36 references indexed in Scilit:
- The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) StatementPLOS Medicine, 2015
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantationWorld Journal of Surgical Oncology, 2015
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma PatientsSeminars in Oncology, 2014
- Predicting Survival after Liver Transplantation Based on Pre-Transplant MELD Score: a Systematic Review of the LiteraturePLOS ONE, 2013
- Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantationWorld Journal of Gastroenterology, 2013
- The clinical relevance of the anhepatic phase during liver transplantationLiver Transplantation, 2009
- Extracapsular Penetration is a New Prognostic Factor in Human Hepatocellular CarcinomaAmerican Journal of Surgical Pathology, 2008
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001